Donning an augmented reality headset in the cockpit, a veteran F-22 pilot just had a dogfight with a projection of a Chinese J-20 fighter.
With hand sanitizer being one of the top sellers on the market since Covid-19 I wonder how quickly these bugs will turn into superbugs?
How worried should we be about bacteria with an alcohol tolerance? Be afraid, be very afraid.
Virgin Hyperloop, the transportation company owned by business magnate Richard Branson, has ambitious plans to build a vacuum tube transportation system that travels over 600 miles per hour.
But before it does so, the company has made the reasonable decision to figure out what traveling that quickly might to do the brain. To wit, scientists at West Virginia’s Rockefeller Neurosciences Institute (RNI) will find out what to expect when launching passengers at 78 percent the speed of sound.
Hold on to your brains!
…BIOS is doing pretty much the same thing as Neuralink — only in many respects better.
Elon Musk’s Neuralink wants to hack the brain – here are the European neurotechnology startups that are doing the same with a lot less funding.
“This is kind of a nice bookend to 16 years of research,” says Deisseroth, a neuroscientist and bioengineer at Stanford University. “It took years and years for us to sort out how to make it work.”
“The result is described this month in the journal Nature Biotechnology.”
“Optogenetics involves genetically engineering animal brains to express light-sensitive proteins—called opsins—in the membranes of neurons.”
Continue reading “No Implants Needed For Precise Control Deep Into The Brain” »
“In a breakthrough study published on February 19th in Nature Biomedical Engineering, researchers connected neural dust implants reduced to 1.7 cubic millimeters to rat sciatic nerves. The implanted device, called the StimDust system, consisted of very few components, which will be scaled down for future applications. A piezoceramic ultrasonic transducer generated power allowing for wireless communication and stimulation. A capacitor stored any excess energy generated from ultrasonic beams. Bipolar stimulating electrodes directly interfaced with the nerve while a cuff attached to a small circuit-board allowed the device to adhere physically to the nerve. These components were sufficient to generate or record nerve-impulses. In anesthetized rodents, they elicited muscular contractions with the StimDust system.”
While Neuralink, Elon Musk’s startup-venture focused on creating a brain-computer interface, garners lots of coverage in the biotechnology space, other bioelectronics ventures continue innovating in this space.
iota Biosciences, a spin-off company from UC Berkley formed in 2017, made news two years ago by securing $15 million in Series A funding and again last year announcing a partnership with Astellas Pharma Inc. Bolstered by studies in rodents, iota Biosciences advances towards their vision. In a press release on their partnership, founders Jose Carmena and Michel Maharbiz commented:
Continue reading “Neural Dust: Millimeter-Sized Brain Stimulators” »
Rock-climb without fear. Play a symphony in your head. See radar with superhuman vision. Discover the nature of consciousness. Cure blindness, paralysis, deafness, and mental illness. Those are just a few of the applications that Elon Musk and employees at his four-year-old neuroscience company Neuralink believe electronic brain-computer interfaces will one day bring about.
None of these advances are close at hand, and some are unlikely to ever come about. But in a “product update” streamed over YouTube on Friday, Musk, also the founder of SpaceX and Tesla Motors, joined staffers wearing black masks to discuss the company’s work toward an affordable, reliable brain implant that Musk believes billions of consumers will clamor for in the future.
Continue reading “Elon Musk’s Neuralink is neuroscience theater” »
In a major breakthrough an international team of scientists, led by the University of Bristol, has potentially identified what makes SARS-CoV-2 highly infectious and able to spread rapidly in human cells. The findings, published in Science today [20 October] describe how the virus’s ability to infect human cells can be reduced by inhibitors that block a newly discovered interaction between virus and host, demonstrating a potential anti-viral treatment.
“In a world first, a “cold-shock” protein has been found in the blood of regular winter swimmers at London’s Parliament Hill Lido.”
“The protein has been shown to slow the onset of dementia and even repair some of the damage it causes in mice.”
“Prof Giovanna Mallucci, who runs the UK Dementia Research Institute’s Centre at the University of Cambridge, says the discovery could point researchers towards new drug treatments which may help hold dementia at bay.”
Continue reading “Could cold water hold a clue to a dementia cure?” »
“Our DIY Covid-19 DNA vaccine showed neutralizing antibodies in all three individuals, Me, David Ishee Dariia Dantseva
That was exciting but our goal was to teach people how to test expression in human cells, perform ELISAs &c. and that was more important.
People wrongly think I am completely against the FDA. I’m not. They are good at what they do i.e. helping drug companies make money by making mass produced drugs that help the most amount of people and hurt the least amount of people.
Continue reading “Home-Made Covid Vaccine Appeared to Work, but Questions Remained” »
